Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline
- Author(s)
- Sessa, C; Balmana, J; Bober, SL; Cardoso, MJ; Colombo, N; Curigliano, G; Domchek, SM; Evans, DG; Fischerova, D; Harbeck, N; Kuhl, C; Lemley, B; Levy-Lahad, E; Lambertini, M; Ledermann, JA; Loibl, S; Phillips, KA; Paluch-Shimon, S; ESMO Guidelines Committee;
- Details
- Publication Year 2023-01,Volume 34,Issue #1,Page 33-47
- Journal Title
- Annals of Oncology
- Publication Type
- Guideline
- Publisher
- Elsevier
- Keywords
- Humans; Female; Early Detection of Cancer; *Breast Neoplasms/diagnosis/genetics/prevention & control; *Neoplastic Syndromes, Hereditary; *Ovarian Neoplasms/diagnosis/epidemiology/genetics; Risk Reduction Behavior; Genetic Predisposition to Disease; Brca; ESMO Clinical Practice Guideline; hereditary breast and ovarian cancer syndromes; risk reduction
- Department(s)
- Medical Oncology
- PubMed ID
- 36307055
- Publisher's Version
- https://doi.org/10.1016/j.annonc.2022.10.004
- Open Access at Publisher's Site
- http://doi.org/10.1016/j.annonc.2022.10.004
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2023-06-13 07:55:27
Last Modified: 2024-07-16 06:25:58